In a significant move set to revolutionize India’s poultry industry, Alembic Pharmaceuticals and Amlan International, the animal health division of Oil-Dri Corporation of America, have forged a strategic commercial alliance. This collaboration aims to introduce cutting-edge poultry health solutions across India, promising enhanced efficiency and sustainability for farmers nationwide.
This partnership comes at a crucial time when the demand for high-quality protein is soaring. By combining their strengths, Alembic Pharma and Amlan International will expand access to advanced feed additives. These innovative solutions are designed to dramatically improve gut health, optimize nutrient absorption, and boost feed conversion ratios (FCR). The ultimate result? Better poultry yields and a stronger, more resilient poultry sector.
Beyond product introduction, the agreement also lays the groundwork for a comprehensive framework encompassing knowledge sharing, technical training, and fostering sustainable growth within India’s dynamic poultry landscape.
Shaunak Amin, Managing Director of Alembic Pharmaceuticals, highlighted the strategic importance of this alliance. “This partnership allows us to bring scientifically backed, practical solutions to poultry farmers across India,” he stated. “With Amlan’s expertise in toxin binders and gut health, combined with our strong market presence, we’re not just introducing new products; we’re directly addressing key challenges faced by poultry farmers.”
Opening Doors for Innovation
- Karunanithi, Executive Vice President (Cluster Head), Animal Health Division at Alembic Pharmaceuticals, emphasized the foundational role of gut health in poultry production. “Poultry production efficiency starts with a healthy intestinal environment,” he explained. “By integrating Amlan’s innovative feed additive technologies into our portfolio, we are strengthening our commitment to delivering science-backed solutions that enhance poultry health and performance.”
Dr. W. Wade Robey, VP Agriculture and President with Amlan International, USA, expressed similar enthusiasm about the collaboration. “This strong foundation of partnership will open the door for innovative and research-based products, broadly reaching India’s poultry and feed milling sector,” he remarked.
Amlan International’s parent company, Oil-Dri Corporation of America, brings over 80 years of expertise in sorbent mineral technology. A global leader, Oil-Dri selectively mines and processes its unique minerals for both consumer and business markets, underscoring the deep scientific foundation supporting this new venture.
This collaboration between Alembic Pharmaceuticals and Amlan International is poised to usher in a new era of efficiency and health for India’s poultry industry, benefiting farmers, consumers, and the nation’s agricultural economy.
